Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Grass Sublingual Tablet (Grastek) in Adults with Rhinoconjunctivitis
NCT00562159Phase 3Completed
- Sponsor
- ALK-Abelló
- Start
- Nov 2007
- Primary completion
- Sep 2009
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 3 trial of SQ SLIT-tablet in allergic rhinoconjunctivitis (ARC), sponsored by ALK-Abelló. Started Nov 2007; status: completed.
02
Drugs
SQ SLIT-tablet
03
Conditions
allergic rhinoconjunctivitis (ARC)
Beyond the preview
Go deeper on NCT00562159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00562159.